TY - JOUR
T1 - MRI and Mammography Surveillance of Women at Increased Risk for Breast Cancer. Recommendations Using an Evidence-based Approach
AU - Granader, Elon J.
AU - Dwamena, Ben
AU - Carlos, Ruth C.
PY - 2008/12
Y1 - 2008/12
N2 - Rationale and Objectives: To evaluate breast cancer screening with mammography and magnetic resonance imaging (MRI) in high-risk populations, including women with the BRCA mutation, using an evidence-based approach. Methods: The MEDLINE, PubMed, EBM Reviews, ACP Journal Club, Cochrane Database MEDSEARCH, and SCOPUS databases were accessed and searched for articles up to August 2007. Articles were collected using the following terms and medical subject headings (MeSH) that applied to the focused clinical question: "BRCA1" and "BRCA2" with "mammography," "MRI," "prevention," "screening," and "surveillance." References from retrieved articles were also used to identify relevant papers. Abstracts were screened and relevant papers retrieved. Retrieved papers were graded for quality. Summary performance measures were obtained by random effects modeling of study-specific performance estimates and standard errors derived from the multiple 2 × 2 tables. Additionally, studies meeting the Centre for Evidence-Based Medicine level 2b quality were reviewed. Results: In women with an increased risk without the BRCA gene, cancer detection rates by MRI were 0.011 (95% confidence interval [CI] 0.003-0.019), by mammography 0.005 (95% CI 0.002-0.008), and by a combination of both, 0.012 (95% CI 0.004-0.020). False-positive rates by MRI, mammography, or a combination of both were 0.10 (95% CI 0.03-0.18), 0.05 (95% CI 0.03-0.06), and 0.14 (95% CI 0.04-0.24). In BRCA positive women, cancer detection rates by MRI were 0.027 (95% CI 0.015-0.040), by mammography 0.010 (95% CI 0.005-0.016), and by a combination of both 0.031 (95% CI 0.018-0.045). False-positive rates by MRI, mammography, or a combination of both were 0.10 (95% CI 0.01-0.19), 0.05 (95% CI 0.03-0.07), and 0.14 (95% CI 0.04-0.24), respectively. Conclusions: The data support an essential role for screening MRI in women with an increased risk for breast cancer.
AB - Rationale and Objectives: To evaluate breast cancer screening with mammography and magnetic resonance imaging (MRI) in high-risk populations, including women with the BRCA mutation, using an evidence-based approach. Methods: The MEDLINE, PubMed, EBM Reviews, ACP Journal Club, Cochrane Database MEDSEARCH, and SCOPUS databases were accessed and searched for articles up to August 2007. Articles were collected using the following terms and medical subject headings (MeSH) that applied to the focused clinical question: "BRCA1" and "BRCA2" with "mammography," "MRI," "prevention," "screening," and "surveillance." References from retrieved articles were also used to identify relevant papers. Abstracts were screened and relevant papers retrieved. Retrieved papers were graded for quality. Summary performance measures were obtained by random effects modeling of study-specific performance estimates and standard errors derived from the multiple 2 × 2 tables. Additionally, studies meeting the Centre for Evidence-Based Medicine level 2b quality were reviewed. Results: In women with an increased risk without the BRCA gene, cancer detection rates by MRI were 0.011 (95% confidence interval [CI] 0.003-0.019), by mammography 0.005 (95% CI 0.002-0.008), and by a combination of both, 0.012 (95% CI 0.004-0.020). False-positive rates by MRI, mammography, or a combination of both were 0.10 (95% CI 0.03-0.18), 0.05 (95% CI 0.03-0.06), and 0.14 (95% CI 0.04-0.24). In BRCA positive women, cancer detection rates by MRI were 0.027 (95% CI 0.015-0.040), by mammography 0.010 (95% CI 0.005-0.016), and by a combination of both 0.031 (95% CI 0.018-0.045). False-positive rates by MRI, mammography, or a combination of both were 0.10 (95% CI 0.01-0.19), 0.05 (95% CI 0.03-0.07), and 0.14 (95% CI 0.04-0.24), respectively. Conclusions: The data support an essential role for screening MRI in women with an increased risk for breast cancer.
KW - BRCA
KW - Magnetic resonance imaging (MRI)
KW - breast cancer
KW - mammography
KW - surveillance
UR - http://www.scopus.com/inward/record.url?scp=55349103791&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55349103791&partnerID=8YFLogxK
U2 - 10.1016/j.acra.2008.06.006
DO - 10.1016/j.acra.2008.06.006
M3 - Article
C2 - 19000876
AN - SCOPUS:55349103791
SN - 1076-6332
VL - 15
SP - 1590
EP - 1595
JO - Academic Radiology
JF - Academic Radiology
IS - 12
ER -